SP1 and non-small cell lung carcinoma: In conclusion, we found that miR-145-5p is involved in the resistance mechanism of NSCLC cells to pemetrexed treatment through the inhibition of Sp1, while miR-145-5p is negatively regulated by BMI1 in the NSCLC cells.